Lotus Eye Hospital and Institute
Lotus Eye Hospital And Institute Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in Lotus Eye Hospital and Institute
Start SIPLotus Eye Hospital And Institute F&O
Lotus Eye Hospital And Institute Investment Rating
-
Master Rating:
-
Lotus Eye Hospital And Institute has an operating revenue of Rs. 46.44 Cr. on a trailing 12-month basis. An annual revenue growth of 20% is outstanding, Pre-tax margin of 11% is healthy, ROE of 5% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 65 which is a FAIR score but needs to improve its earnings, a RS Rating of 45 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C which is evident from recent supply seen, Group Rank of 46 indicates it belongs to a fair industry group of Medical-Hospitals and a Master Score of D is close to being the worst. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|---|
| Oper Rev Qtr Cr | 12 | 12 | 12 | 11 |
| Operating Expenses Qtr Cr | 10 | 10 | 10 | 9 |
| Operating Profit Qtr Cr | 2 | 2 | 2 | 1 |
| Depreciation Qtr Cr | 1 | 1 | 1 | 1 |
| Interest Qtr Cr | 0 | 0 | 0 | 0 |
| Tax Qtr Cr | 0 | 0 | 0 | 0 |
| Net Profit Qtr Cr | 1 | 1 | 1 | 1 |
Lotus Eye Hospital And Institute Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 2
- Bearish Moving Average
- ___
- 14
- 20 Day
- 61.12
- 50 Day
- 65.59
- 100 Day
- 68.59
- 200 Day
- 67.43
- 20 Day
- 61.08
- 50 Day
- 66.23
- 100 Day
- 73.42
- 200 Day
- 69.02
Lotus Eye Hospital And Institute Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 59.89 |
| Second Resistance | 62.27 |
| Third Resistance | 64.04 |
| RSI | 37.72 |
| MFI | 44.84 |
| MACD Single Line | -2.37 |
| MACD | -2.36 |
| Support | |
|---|---|
| First Resistance | 55.74 |
| Second Resistance | 53.97 |
| Third Resistance | 51.59 |
Lotus Eye Hospital And Institute Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 2,469 | 177,299 | 71.81 |
| Week | 6,154 | 454,676 | 73.88 |
| 1 Month | 6,825 | 438,587 | 64.26 |
| 6 Month | 37,486 | 2,112,715 | 56.36 |
Lotus Eye Hospital And Institute Result Highlights
Lotus Eye Hospital and Institute Synopsis
NSE-Medical-Hospitals
Lotus Eye Hospital belongs to the Industry of Hospitals & Medical Services. Company’s Total Operating Revenue is Rs. 38.91 Cr. and Equity Capital is Rs. 20.80 Cr. for the Year ended 31/03/2022. Lotus Eye Hospital and Institute Ltd. is a Public Limited Listed company incorporated on 14/03/1997 and has its registered office in the State of Tamil Nadu, India. Company’s Corporate Identification Number(CIN) is L85110TZ1997PLC007783 and registration number is 007783.| Market Cap | 122 |
| Sales | 46 |
| Shares in Float | 0.87 |
| No of funds | 1 |
| Yield | 0.85 |
| Book Value | 2.23 |
| U/D Vol ratio | 0.5 |
| LTDebt / Equity | |
| Alpha | 0.11 |
| Beta | 1.09 |
Lotus Eye Hospital and Institute
| Owner Name | Dec-22 | Sep-22 | Jun-22 |
|---|---|---|---|
| Promoters | 58.14% | 57.88% | 57.74% |
| Foreign Portfolio Investors | |||
| Individual Investors | 21.8% | 23.13% | 27.13% |
| Others | 20.06% | 18.99% | 15.13% |
Lotus Eye Hospital and Institute Management
| Name | Designation |
|---|---|
| Dr. Kavetha Sundaramoorthy | Chairman |
| Ms. Sangeetha Sundaramoorthy | Managing Director |
| Dr. K S Ramalingam | Executive Director & CEO |
| Mr. D R Kaarthikeyan | Director |
| Dr. Yogesh Shah | Director |
| CA. R Subramanian | Director |
| CA. M Alagiriswamy | Director |
| Dr. S Natesan | Director |
Lotus Eye Hospital And Institute Forecast
Price Estimates
Lotus Eye Hospital and Institute FAQs
What is Share Price of Lotus Eye Hospital and Institute ?
Lotus Eye Hospital and Institute share price is ₹58 As on 01 April, 2023 | 12:41
What is the Market Cap of Lotus Eye Hospital and Institute ?
The Market Cap of Lotus Eye Hospital and Institute is ₹121.9 Cr As on 01 April, 2023 | 12:41
What is the P/E ratio of Lotus Eye Hospital and Institute ?
The P/E ratio of Lotus Eye Hospital and Institute is 30.7 As on 01 April, 2023 | 12:41
What is the PB ratio of Lotus Eye Hospital and Institute ?
The PB ratio of Lotus Eye Hospital and Institute is 2.2 As on 01 April, 2023 | 12:41